Kolexia
Dulucq Stephanie Pharmacien
Dulucq Stephanie
Pharmacien
Hôpital Pellegrin
Bordeaux, France
94 Activités
3 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémie myéloïde chronique BCR-ABL positive Leucémies Leucémie myéloïde Leucémie myéloïde en phase chronique Crise blastique Récidive tumorale locale Maladie résiduelle Leucémie aigüe myéloïde Tumeurs hématologiques

Collaborateurs

Voir plus
Mahon Francois-Xavier
Mahon Francois-Xavier
Institut Bergonié, Bordeaux, France
Etienne Gabriel
Etienne Gabriel
Institut Bergonié, Bordeaux, France
Nicolini Franck
Nicolini Franck
Centre Léon-Bérard, Lyon, France
Rea Delphine
Rea Delphine
Hôpital Saint-Louis, Paris, France

Industries

Voir plus
Novartis
14 collaboration(s)
Dernière en 2023
Incyte
9 collaboration(s)
Dernière en 2023
Sanofi
3 collaboration(s)
Dernière en 2023
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients.
British journal of haematology   07 février 2024
Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure: A Report from the Residiag Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
T rial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting. Report of the First Therapeutic Sequence
65th ASH Annual Meeting Abstracts   02 novembre 2023
CML Piramid: CML Pediatric ITK Response According to Molecular Identification at Diagnosis (CML Piramid
Essai Clinique (CHU Bordeaux)   26 octobre 2023
Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study.
British journal of haematology   02 avril 2023
Specific High-Sensitivity Enzymatic Reporter UnLOCKing-Mediated Detection of Oncogenic and Rearrangements.
The CRISPR journal   13 mars 2023
Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission.
Haematologica   01 décembre 2022
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial.
Haematologica   01 décembre 2022
Treatment-Free Remission in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib Front-Line, in Real-Life Conditions: Influence of Switching to Another TKI Prior to Cessation.
Annual Meeting Abstracts 2022   15 novembre 2022
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.
Leukemia   25 mai 2022